Crossmark

Focal laser for idiopathic macular telangectasia type 1 refractory to ozurdex, ranibizumab and aflibercept

Crossref DOI link: https://doi.org/10.1016/j.oftale.2020.03.012

Published Print: 2021-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Tapia Quijada, H.E.

Gómez Perera, S.

Rodríguez Talavera, I.

Mantolan Sarmiento, C.

Rocha Cabrera, P.

Díaz de Aguilar Osona, M.

Serrano García, M.
License Information

Text and Data Mining valid from 2021-03-01
More Information

This article is maintained by: Elsevier

Article Title: Focal laser for idiopathic macular telangectasia type 1 refractory to ozurdex, ranibizumab and aflibercept

Journal Title: Archivos de la Sociedad Española de Oftalmología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.oftale.2020.03.012

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.oftal.2020.03.022

Content Type: article

Copyright: © 2020 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.